Kibur Medical is a cutting-edge brand that is transforming cancer care through their innovative technology and solutions. They offer a comprehensive molecular profiling of tumor response to up to 20 different oncology drugs or drug combinations simultaneously. This approach allows drug developers to design more potent and better-tolerated oncology drugs with a higher chance of clinical success.

The Kibur Medical technology provides direct measurement of tumor response, helping to identify effective therapies for patients who don't respond to standard-of-care treatment. The current challenge in pre-clinical oncology development is the lack of accurate replication of human tumor biology, leading to increased risk and cost of failure. However, Kibur Medical's solution addresses this issue with their tumor-implanted, drug-eluting NanoNail™.

This device allows for in situ molecular profiling of tumor response and provides deep molecular information on drug-tumor interaction. With the ability to measure in vivo functional activity of multiple compounds simultaneously, the Kibur solution minimizes development risk, reduces clinical attrition, and saves costs. Overall, Kibur Medical is revolutionizing cancer care by accelerating a new era in precision oncology drug and diagnostic development